Dexmeditomedine Versus No Sedation in Management of Agitation in COPD Patients Receiving Noninvasive Ventilation

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT05774145

Enrollment

Registered

2023-03-17

Start date

2023-03-31

Completion date

2025-12-31

Last updated

2023-03-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COPD

Brief summary

The aim is to compare sedation using dexmedetomidine to sedation -free approach in management of agitated COPD patients receiving NIV

Detailed description

The aim is to compare sedation using dexmedetomidine to sedation -free approach in management of agitated COPD patients receiving NIV

Interventions

None listed

Study design

Observational model

CASE_CONTROL

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 100 Years

Healthy volunteers

Yes

Inclusion criteria

Inclusion critera * age\>18 * Agitation * NIV intolerance

Exclusion criteria

* cardiac dysfunction * Hepatic dysfunction * Haemodynamic instability

Design outcomes

Primary

Measure	Time frame	Description
precedex on COPD irritable on non invasive machine	3/2023_3/2025	control of Agitation by RASS

Outcome results